NCT02319941View on ClinicalTrials.gov

Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes

PHASE2CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

May 20, 2015

Primary Completion Date

February 14, 2017

Study Completion Date

March 10, 2017

Conditions

Acute Coronary Syndrome

Interventions

DRUG

ticagrelor

DRUG

clopidogrel

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (2)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

collaborator

KBM pharm

UNKNOWN

lead

Seung-Jung Park

OTHER